CHRISTA YOUNG: Open Payments
NPI 1518688092 · ASHEBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,504 in 149 payments from 25 companies in 2025. Trend: 2023 $2,932 · 2024 $2,377 · 2025 $2,504
Food & beverage: $2,504
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 17 | $220 |
| Vanda Pharmaceuticals Inc. | 6 | $217 |
| Novo Nordisk Inc | 11 | $194 |
| Otsuka America Pharmaceutical, Inc. | 10 | $189 |
| AstraZeneca Pharmaceuticals LP | 11 | $189 |
| Phathom Pharmaceuticals, Inc. | 5 | $173 |
| Lilly USA, LLC | 12 | $170 |
| Eisai Inc. | 5 | $144 |
| Kowa Pharmaceuticals America, Inc. | 24 | $144 |
| GlaxoSmithKline, LLC. | 6 | $117 |
Products named: FANAPT, REXULTI, VOQUEZNA, Ozempic, Leqembi, ZORYVE, MOUNJARO, TRELEGY ELLIPTA.
Industry payments across NC — which companies pay providers there.
